×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [4]
中南大学 [2]
吉林大学白求恩第一医... [2]
山东大学 [1]
武汉大学 [1]
昆明医科大学 [1]
更多...
内容类型
期刊论文 [12]
发表日期
2018 [12]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
发表日期:2018
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:
Qin, Shukui
;
Li, Jin
;
Wang, Liwei
;
Xu, Jianming
;
Cheng, Ying
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/04
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:
Xiong, Jianping
;
Qin, Shukui
;
Li, Jin
;
Wang, Liwei
;
Xu, Jianming
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/05
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
期刊论文
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 卷号: 319, 期号: 24
作者:
Cheng, Ying
;
Li, Jin
;
Qin, Shukui
;
Xu, Rui-Hua
;
Shen, Lin
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/12/05
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:
Ouyang, Xuenong
;
Shi, Meiqi
;
Jie, Fangwei
;
Bai, Yuxian
;
Shen, Peng
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
Phase III
Dulanermin
NSCLC
Progression-free survival
Objective response rate
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
期刊论文
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 卷号: 319, 期号: 24
作者:
Li, Jin
;
Qin, Shukui
;
Xu, Rui-Hua
;
Shen, Lin
;
Xu, Jianming
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30
作者:
Qin, Shukui
;
Li, Jin
;
Wang, Liwei
;
Xu, Jianming
;
Cheng, Ying
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)
期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:
Liu, Xinyang
;
Qin, Shukui
;
Wang, Zhichao
;
Xu, Jianming
;
Xiong, Jianping
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/05
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial.
期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 卷号: 36, 期号: 30, 页码: JCO2018783183
作者:
Qin, Shukui
;
Li, Jin*
;
Wang, Liwei
;
Xu, Jianming
;
Cheng, Ying
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/03
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
期刊论文
JAMA, 2018, 卷号: 319, 期号: 24, 页码: 2486-2496
作者:
Li, Jin
;
Qin, Shukui*
;
Xu, Rui-Hua
;
Shen, Lin
;
Xu, Jianming
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/03
adverse event
chemotherapy regimen
china
colorectal cancer metastatic
fruquintinib
toxic effect
tumor progression
vascular endothelial growth factor receptors
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
期刊论文
INVESTIGATIONAL NEW DRUGS, 2018, 卷号: 36, 期号: 2
作者:
Ouyang, Xuenong
;
Shi, Meiqi
;
Jie, Fangwei
;
Bai, Yuxian
;
Shen, Peng
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/12/05
Phase III
Dulanermin
NSCLC
Progression-free survival
Objective response rate
©版权所有 ©2017 CSpace - Powered by
CSpace